Matches in Wikidata for { <http://www.wikidata.org/entity/Q97675331> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q97675331 description "article scientifique publié en 2020" @default.
- Q97675331 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97675331 description "scientific article published on 22 July 2020" @default.
- Q97675331 description "wetenschappelijk artikel" @default.
- Q97675331 description "наукова стаття, опублікована 22 липня 2020" @default.
- Q97675331 description "գիտական հոդված հրատարակված 2020 թվականի հուլիսի 22-ին" @default.
- Q97675331 name "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 name "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 type Item @default.
- Q97675331 label "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 label "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 prefLabel "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 prefLabel "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 P1433 Q97675331-8B7733DF-28A1-43F8-A927-B48C3D180364 @default.
- Q97675331 P1476 Q97675331-CB207C80-0665-4A3B-B8AE-5E5FAC99D566 @default.
- Q97675331 P2093 Q97675331-09C4CFCD-8CE4-4A51-91EA-EF44A4B0A640 @default.
- Q97675331 P2093 Q97675331-12DD8D52-62C3-4791-83E1-8C8BB8B4EF48 @default.
- Q97675331 P2093 Q97675331-25D37BA3-4749-4444-AF42-F793DBECF23D @default.
- Q97675331 P2093 Q97675331-5736684F-6D09-4022-9D83-101846A26957 @default.
- Q97675331 P2093 Q97675331-6C65F126-3C97-45C5-A4BA-8E9ED8C9CE2E @default.
- Q97675331 P2093 Q97675331-700A944D-C2AD-4B7E-B4D8-B0CE685DFC36 @default.
- Q97675331 P2093 Q97675331-C05E515B-2710-443B-842F-A30EA3D6DA67 @default.
- Q97675331 P2093 Q97675331-C354B1A7-3C5D-4E69-9A3E-066B53942119 @default.
- Q97675331 P2093 Q97675331-D1D8A659-5556-410C-966B-1DB2B19CD99B @default.
- Q97675331 P2093 Q97675331-F5BAAC7E-66A8-4844-9817-6F52625FCFB4 @default.
- Q97675331 P31 Q97675331-F29E4459-36DD-48BB-B289-8CE0B142F6BD @default.
- Q97675331 P356 Q97675331-EE0F59CD-D33E-4A22-BC6A-F2EEB190A1C3 @default.
- Q97675331 P50 Q97675331-664DC4BF-D4E1-46FB-A653-DB81D70B5BE7 @default.
- Q97675331 P50 Q97675331-A4FA5306-E59A-4BAA-9ACA-279BC264F3B7 @default.
- Q97675331 P577 Q97675331-AC4DAE9D-30A8-477D-90DA-05EA82316D6C @default.
- Q97675331 P698 Q97675331-6E5D8C5B-9771-40A1-9553-17B8F6112B9B @default.
- Q97675331 P356 BJH.16982 @default.
- Q97675331 P698 32700338 @default.
- Q97675331 P1433 Q4970200 @default.
- Q97675331 P1476 "CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease" @default.
- Q97675331 P2093 "Changju Qu" @default.
- Q97675331 P2093 "Depei Wu" @default.
- Q97675331 P2093 "Guanghua Chen" @default.
- Q97675331 P2093 "Jia Yin" @default.
- Q97675331 P2093 "Lei Yu" @default.
- Q97675331 P2093 "Liqing Kang" @default.
- Q97675331 P2093 "Mingqing Zhu" @default.
- Q97675331 P2093 "Suning Chen" @default.
- Q97675331 P2093 "Xiaowen Tang" @default.
- Q97675331 P2093 "Zheng Li" @default.
- Q97675331 P31 Q13442814 @default.
- Q97675331 P356 "10.1111/BJH.16982" @default.
- Q97675331 P50 Q87918794 @default.
- Q97675331 P50 Q97675330 @default.
- Q97675331 P577 "2020-07-22T00:00:00Z" @default.
- Q97675331 P698 "32700338" @default.